Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Goossens

Showing results (61-70 of 95) with videos related to

Pageof 10
Sort By:
Haematologica|June 5, 2014
MicroRNA-128-3p is a novel oncomiR targeting PHF6 in T-cell acute lymphoblastic leukemiaEvelien Mets, Gert Van Peer, Joni Van der Meulen, et al.
Nucleic Acids Research|March 13, 2009
Efficient mouse transgenesis using Gateway-compatible ROSA26 locus targeting vectors and F1 hybrid ES cellsOmar Nyabi, Michael Naessens, Katharina Haigh, et al.
Oncogene|November 21, 2023
Dual targeting of MAPK and PI3K pathways unlocks redifferentiation of Braf-mutated thyroid cancer organoidsHélène Lasolle, Andrea Schiavo, Adrien Tourneur, et al.
Haematologica|August 18, 2022
<i>In vivo</i> stabilization of a less toxic asparaginase variant leads to a durable antitumor response in acute leukemiaMaaike Van Trimpont, Amanda M Schalk, Yanti De Visser, et al.
Iscience|November 18, 2024
ZEB2 drives intra-tumor heterogeneity and skin squamous cell carcinoma formation with distinct EMP transition statesJeroen Verstappe, Nicolas Skrypek, Jordy De Coninck, et al.
The EMBO Journal|December 17, 2009
Increased skeletal VEGF enhances beta-catenin activity and results in excessively ossified bonesChrista Maes, Steven Goossens, Sonia Bartunkova, et al.
Blood|January 11, 2017
Oncogenic ZEB2 activation drives sensitivity toward KDM1A inhibition in T-cell acute lymphoblastic leukemiaSteven Goossens, Sofie Peirs, Wouter Van Loocke, et al.
Science Advances|November 1, 2024
A dual role for PSIP1/LEDGF in T cell acute lymphoblastic leukemiaLisa Demoen, Filip Matthijssens, Lindy Reunes, et al.
Molecular Cancer Research : MCR|June 24, 2022
Distinct Transcriptional Programs in Ascitic and Solid Cancer Cells Induce Different Responses to Chemotherapy in High-Grade Serous Ovarian CancerNele Loret, Niels Vandamme, Jordy De Coninck, et al.
Blood|September 30, 2016
The EMT transcription factor Zeb2 controls adult murine hematopoietic differentiation by regulating cytokine signalingJin Li, Tamara Riedt, Steven Goossens, et al.
Pageof 10

Showing results (61-70 of 95) with videos related to

Sort By:
Pageof 10
Haematologica|June 5, 2014
MicroRNA-128-3p is a novel oncomiR targeting PHF6 in T-cell acute lymphoblastic leukemiaEvelien Mets, Gert Van Peer, Joni Van der Meulen, et al.
Nucleic Acids Research|March 13, 2009
Efficient mouse transgenesis using Gateway-compatible ROSA26 locus targeting vectors and F1 hybrid ES cellsOmar Nyabi, Michael Naessens, Katharina Haigh, et al.
Oncogene|November 21, 2023
Dual targeting of MAPK and PI3K pathways unlocks redifferentiation of Braf-mutated thyroid cancer organoidsHélène Lasolle, Andrea Schiavo, Adrien Tourneur, et al.
Haematologica|August 18, 2022
<i>In vivo</i> stabilization of a less toxic asparaginase variant leads to a durable antitumor response in acute leukemiaMaaike Van Trimpont, Amanda M Schalk, Yanti De Visser, et al.
Iscience|November 18, 2024
ZEB2 drives intra-tumor heterogeneity and skin squamous cell carcinoma formation with distinct EMP transition statesJeroen Verstappe, Nicolas Skrypek, Jordy De Coninck, et al.
The EMBO Journal|December 17, 2009
Increased skeletal VEGF enhances beta-catenin activity and results in excessively ossified bonesChrista Maes, Steven Goossens, Sonia Bartunkova, et al.
Blood|January 11, 2017
Oncogenic ZEB2 activation drives sensitivity toward KDM1A inhibition in T-cell acute lymphoblastic leukemiaSteven Goossens, Sofie Peirs, Wouter Van Loocke, et al.
Science Advances|November 1, 2024
A dual role for PSIP1/LEDGF in T cell acute lymphoblastic leukemiaLisa Demoen, Filip Matthijssens, Lindy Reunes, et al.
Molecular Cancer Research : MCR|June 24, 2022
Distinct Transcriptional Programs in Ascitic and Solid Cancer Cells Induce Different Responses to Chemotherapy in High-Grade Serous Ovarian CancerNele Loret, Niels Vandamme, Jordy De Coninck, et al.
Blood|September 30, 2016
The EMT transcription factor Zeb2 controls adult murine hematopoietic differentiation by regulating cytokine signalingJin Li, Tamara Riedt, Steven Goossens, et al.
Pageof 10